临床病理特征 | VCANmRNA表达量 | z值/H值 | P值 |
性别 |
| −2.774 | 0.006 |
男 | 0.54 (0.16, 1.98) |
|
|
女 | 1.26 (0.19, 3.43) |
|
|
年龄 |
| −1.881 | 0.06 |
<60 | 0.89 (0.19, 3.05) |
|
|
≥60 | 0.53 (0.16, 1.94) |
|
|
组织学分级 |
| 4.72 | 0.095 |
高分化(G1) | 0.53 (0.11, 1.50) |
|
|
中分化(G2) | 0.70 (0.16, 2.34) |
|
|
低分化(G3) | 1.11 (0.24, 2.98) |
|
|
TNM分期 |
| 7.968 | 0.048 |
I期 | 0.18 (0.66, 1.79) |
|
|
II期 | 0.73 (0.10, 2.30) |
|
|
III期 | 1.04 (0.24, 3.48) |
|
|
IV期 | 2.47 (0.95, 30.80) |
|
|
T分期 |
| 8.455 | 0.037 |
T1 | 0.66 (0.19, 1.80) |
|
|
T2 | 0.94 (0.12, 2.31) |
|
|
T3 | 1.03 (0.23, 3.24) |
|
|
T4 | 1.24 (0.24, 5.73) |
|
|
淋巴结转移 |
| −1.076 | 0.282 |
N0 | 0.76 (0.17, 2.34) |
|
|
N1 | 3.45 (0.30, 31.52) |
|
|
远处转移 |
| −0.1.87 | 0.235 |
M0 | 0.74 (0.17, 2.36) |
|
|
M1 | 1.59 (0.95, 3.10) |
|
|